Top Losers: XOMA Corp (NASDAQ:XOMA), Endeavour International Corporation (NYSE:END), USEC Inc. (NYSE:USU), Ceres Inc. (NASDAQ:CERE)

310

XOMA Corporation (NASDAQ:XOMA), a leader in the discovery and development of therapeutic antibodies, provided an update on its gevokizumab development program. Based on results from the Company’s Phase 2 program in patients with erosive osteoarthritis of the hand (EOA), XOMA does not intend to launch pivotal development for the broad EOA indication. The Company will conduct a review of the full dataset to determine if there is a segment of the patient population that best responds to gevokizumab therapy prior to initiating any potential additional clinical studies in this indication. On last trading day XOMA Corp (NASDAQ:XOMA) ended up -27.75% lower to close at $6.82 while trading the range of $6.80 – $7.53. Its return on assets (ROA) is -103.90% while return on investment (ROI) is -90.30%.XOMA Corp (NASDAQ:XOMA) monthly performance is -4.21%.

Shares of Endeavour International Corp. (NYSE:END) were the target of unusually large options trading on Wednesday. Stock traders purchased 11,887 put options on the company, Analyst RN reports. This is an increase of approximately 866% compared to the typical daily volume of 1,230 put options. Endeavour International Corporation (NYSE:END) in last trading activity ended up at $3.93 with day range of $3.92 – $5.13. Company weekly performance is -24.42% while its quarterly performance stands at -17.44%. Endeavour International Corporation (NYSE:END) is -47.60% away from its 52 week high.

As expected, USEC Inc. (NYSE:USU) announced Wednesday that it has formally filed a voluntary plan of reorganization in the U.S. Bankruptcy Court for the District of Delaware. USEC Inc. (NYSE:USU) belongs to Basic Materials sector with market capitalization of 21.56M and has 7.97% insider ownership. In last trading activity company’s stock closed at $4.40 while opening price was $4.71.

Shares of agricultural biotech Ceres Inc. (NASDAQ:CERE) fell more than 20 percent Wednesday on news of a low pricing for its secondary offering. On Wednesday shares of Ceres Inc. (NASDAQ:CERE) opened at $1.04 and closed at $1.02. This Year Company’s Earnings per Share (EPS) growth is 39.90% and next year’s estimated EPS growth is 55.60%. Analysts mean target price for Ceres Inc. (NASDAQ:CERE) is $3.67.

Get Free Updates and Stock Alerts!



*We only send one email per week
Share.

Get Winning Stock Alerts!

Our track record speaks for itself! Our last 7 alerts have delivered combined gains in excess of 300% and there are no signs of slowing down. Join UltimateStockAlerts.com now before you miss out on our next big runner!

We will never sell or share your information.